Literature DB >> 15929081

Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study.

Ying Liu1, Manami Inoue, Tomotaka Sobue, Shoichiro Tsugane.   

Abstract

Although a link between female hormonal factors and the risk of lung cancer has been suggested, few studies have examined this association in detail. We investigated the associations between reproductive factors, hormone use and the risk of lung cancer in a population-based prospective study. Self-administered questionnaires were distributed to 44,677 lifelong never-smoking women in 1990-1994 to assess menstrual and reproductive factors and hormone use. After 8-12 years of follow-up, 153 lung cancer cases were diagnosed. Relative risk (RR) and 95% confidence intervals (CI) were calculated using the Cox proportional hazards model. Age at menopause, age at menarche, number of children, age at first live birth, breast feeding and use of hormones were not associated with a risk of lung cancer, either overall or among postmenopausal women or women with natural menopause. Compared to women with both late age at menarche (> or =16) and early age at menopause (< or =50), those with either early age at menarche or late age at menopause had a >2-fold, significant increase in the risk of lung cancer. Induced menopausal women with experience of hormone replacement therapy had a significantly elevated risk compared to naturally menopausal women without female hormone use, with an RR of 2.40 (95% CI 1.07-5.40). These findings suggest that both endogenous and extraneous estrogen may be involved in the etiology of lung cancer. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929081     DOI: 10.1002/ijc.21229

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  58 in total

1.  Reproductive and hormonal factors and the risk of nonsmall cell lung cancer.

Authors:  Cari L Meinhold; Amy Berrington de González; Elise D Bowman; Alina V Brenner; Raymond T Jones; James V Lacey; Christopher A Loffredo; Donna Perlmutter; Sara J Schonfeld; Glenwood E Trivers; Curtis C Harris
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

3.  Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium.

Authors:  Soumaya Ben Khedher; Monica Neri; Alexandra Papadopoulos; David C Christiani; Nancy Diao; Curtis C Harris; Susan Olivo-Marston; Ann G Schwartz; Michele Cote; Anita Koushik; Jack Siemiatycki; Maria Teresa Landi; Rayjean J Hung; John McLaughlin; Eric J Duell; Angeline S Andrew; Irene Orlow; Bernard J Park; Hermann Brenner; Kai-Uwe Saum; Angela C Pesatori; Isabelle Stücker
Journal:  Int J Cancer       Date:  2017-05-10       Impact factor: 7.396

4.  The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

5.  Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.

Authors:  Louise A Brinton; Lauren Schwartz; Margaret R Spitz; Yikyung Park; Albert R Hollenbeck; Gretchen L Gierach
Journal:  Cancer Causes Control       Date:  2012-02-25       Impact factor: 2.506

6.  Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women.

Authors:  Michele L Cote; Wonsuk Yoo; Angela S Wenzlaff; Geoffrey M Prysak; Susan K Santer; Gina B Claeys; Alison L Van Dyke; Susan J Land; Ann G Schwartz
Journal:  Carcinogenesis       Date:  2009-01-27       Impact factor: 4.944

7.  Reproductive factors and risk of lung cancer in female textile workers in Shanghai, China.

Authors:  Lisa G Gallagher; Karin A Rosenblatt; Roberta M Ray; Wenjin Li; Dao L Gao; Katie M Applebaum; Harvey Checkoway; David B Thomas
Journal:  Cancer Causes Control       Date:  2013-04-13       Impact factor: 2.506

8.  Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.

Authors:  Rowan T Chlebowski; Heather Wakelee; Mary Pettinger; Thomas Rohan; Jingmin Liu; Michael Simon; Hilary Tindle; Catherine Messina; Karen Johnson; Ann Schwartz; Margery Gass; Jean Wactawski-Wende
Journal:  Clin Lung Cancer       Date:  2015-10-22       Impact factor: 4.785

9.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.

Authors:  Rowan T Chlebowski; Ann G Schwartz; Heather Wakelee; Garnet L Anderson; Marcia L Stefanick; JoAnn E Manson; Rebecca J Rodabough; Jason W Chien; Jean Wactawski-Wende; Margery Gass; Jane Morley Kotchen; Karen C Johnson; Mary Jo O'Sullivan; Judith K Ockene; Chu Chen; F Allan Hubbell
Journal:  Lancet       Date:  2009-09-18       Impact factor: 79.321

10.  Hormone use and lung cancer incidence: the Rancho Bernardo cohort study.

Authors:  Joshua R Smith; Elizabeth Barrett-Connor; Donna Kritz-Silverstein; Deborah L Wingard; Wael K Al-Delaimy
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.